Product Code: SR1323A500_Report
The global breast implant market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028.
Breast implants refer to a prosthesis device, which is formulated from the silicon outer shell that is stuffed with a blend of silicone gel and saline. This process is extensively deployed in cosmetic surgery for enhancing and changing the size, shape, and contour of the breast by replacing and removing tissue. Breast implants surgery includes anesthesia, incision, insertion, placement, and closing of the devices with layered sutures or surgical tape in the breast tissue. At present, the breast implant is commercially available in varying types, such as saline, silicone, structured, gummy bear, round, textured and smooth breast implants.
Breast Implant Market Trends:
- The increasing demand for breast implantation and cosmetic surgeries, along with the rising inclination of consumers toward maintaining an aesthetic appeal, is one of the key factors influencing the global breast implant market growth. Additionally, the escalating prevalence of breast cancer is fueling the market growth, as these implants are used in breast reconstruction procedures among patients. Moreover, the introduction of technologically advanced hyaluronic acid fillers and stable silicone gel breast implants for offering better resemblance to natural breast tissue is contributing to the market growth. In line with this, the widespread adoption of composite breasts is another growth-inducing factor. Furthermore, continual product launches and collaborations of various brands to sensitize the target audience about the post-surgery complications and associated risks is promoting the breast implant market growth. Various organizations are also forming partnership agreements for developing advanced breast implants using the 3D printing technology. Other factors, including rapid technological advancements, are creating a positive outlook for the market.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global breast implant market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, shape, application and end user.
Breakup by Product:
- Silicone Breast Implants
- Saline Breast Implants
Breakup by Shape:
Breakup by Application:
- Cosmetic Surgery
- Reconstructive Surgery
Breakup by End User:
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc, CEREPLAS, Establishment Labs SA, Global Consolidated Aesthetics Limited, Groupe Sebbin SAS, HansBiomed Co. Ltd., Ideal Implant Inc., Laboratoires Arion, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH Health & Aesthetics GmbH and Sientra Inc.
Key Questions Answered in This Report:
- 1. What was the size of the global breast implant market in 2022?
- 2. What is the expected growth rate of the global breast implant market during 2023-2028?
- 3. What are the key factors driving the global breast implant market?
- 4. What has been the impact of COVID-19 on the global breast implant market?
- 5. What is the breakup of the global breast implant market based on the product?
- 6. What is the breakup of the global breast implant market based on the application?
- 7. What is the breakup of the global breast implant market based on the end user?
- 8. What are the key regions in the global breast implant market?
- 9. Who are the key players/companies in the global breast implant market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Breast Implant Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Silicone Breast Implants
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Saline Breast Implants
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Shape
- 7.1 Round
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Anatomical
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Cosmetic Surgery
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Reconstructive Surgery
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Cosmetology Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Allergan plc
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 SWOT Analysis
- 15.3.2 CEREPLAS
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Establishment Labs SA
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Global Consolidated Aesthetics Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Groupe Sebbin SAS
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 HansBiomed Co. Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 Ideal Implant Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Laboratoires Arion
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Mentor Worldwide LLC (Johnson & Johnson)
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 POLYTECH Health & Aesthetics GmbH
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Sientra Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials